Trial Search Results

T-cell Minimal Residual Disease (MRD) Evaluation Using Flow Cytometric Analysis

To determine if MRD (minimal residual disease) can be found in the blood (only) as opposed to bone marrow in children with ALL (acute lymphoblastic leukemia).

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):

Intervention(s):

  • Procedure: bone marrow aspiration
  • Procedure: peripheral blood sampling

Eligibility


Inclusion Criteria:

   - Children with newly diagnosed T-cell ALL

Ages Eligible for Study

N/A - 18 Years

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Nadeem Mukhtar
6504978815
Not Recruiting